# nanosynth group provides an update on JV agreement with Volz

- Link: https://www.directorstalkinterviews.com/nanosynth-group-provides-an-update-on-jv-agreement-with-volz/4121051903
- Published: 2022-02-10T07:04:45+00:00
- Author: Giles

**nanosynth Group plc** (LON:NNN) has announced that further to the announcement
of the Joint Venture Agreement with inter alia, Volz Holdings v.o.s on 10 December
2021, agreement has been reached for Volz to convert their production line to provide
the capability for nanosynth’s alphaviron layer to be included across Volz’s product
range. This is extremely beneficial to the JV Company, Virosynth Limited, as Volz
are not only a HVAC material provider but also an HVAC filter provider. This means
that by Volz converting their production line to incorporate the Company’s technology
as standard, Virosynth will end up with its first client, with leading edge advantage
in the marketplace and a great reference point for others to see and follow due 
to the benefits Virosynth can deliver for the HVAC market and the reputation Volz
holds in the market.

This is also expected to save Virosynth considerable cash expenditure.

The cost of converting the Volz production line is considerable. It has therefore
been agreed that to save nanosynth having to inject cash into Virosynth to meet 
half the cost of this, it will instead provide a warrant over ordinary shares in
the Company to the shareholders of Volz, namely; Rainer Volz and Jonathan Thornton.

Accordingly, the Company has issued £500,000 of warrants over 50,000,000 shares 
at an exercise price of 1 pence each (a premium of c.29% to the closing mid market
share price on 9 February 2022) to be granted equally to Rainer Volz and Jonathan
Thornton. The Warrants are exercisable for a period of three years from the date
of grant and only upon completion of the conversion of the product line.

**Related Party Transaction**

Jonathan Thornton, as a director of Virosynth, which is a 51% owned subsidiary of
the Company, is considered to be a “related party” as defined under the AIM Rules
and accordingly the grant of Warrants constitutes a related party transaction for
the purposes of Rule 13 of the AIM Rules.

Mark Duffin, Richard Clarke, Dr Felicity Sartain and Dr Gareth Cave, being the Directors
independent of the transaction, consider, having consulted with SP Angel Corporate
Finance LLP, the Company’s Nominated Adviser, that the grant of the Warrants are
fair and reasonable insofar as the Company’s shareholders are concerned.

Share on:
